{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:12:22Z","timestamp":1792005142360,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,8,25]],"date-time":"2013-08-25T00:00:00Z","timestamp":1377388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00277-013-1883-1","type":"journal-article","created":{"date-parts":[[2013,8,24]],"date-time":"2013-08-24T06:14:54Z","timestamp":1377324894000},"page":"425-435","source":"Crossref","is-referenced-by-count":25,"title":["Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia"],"prefix":"10.1007","volume":"93","author":[{"given":"Huayuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,25]]},"reference":[{"key":"1883_CR1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","volume":"352","author":"N Chiorazzi","year":"2005","unstructured":"Chiorazzi N, Rai KR, Ferrarini M (2005) Chronic lymphocytic leukemia. N Engl J Med 352:804\u2013815","journal-title":"N Engl J Med"},{"key":"1883_CR2","first-page":"400","volume":"55","author":"A Berkova","year":"2008","unstructured":"Berkova A, Pavlistova L, Babicka L et al (2008) Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia. Neoplasma 55:400\u2013408","journal-title":"Neoplasma"},{"key":"1883_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","volume":"8","author":"P Cramer","year":"2011","unstructured":"Cramer P, Hallek M (2011) Prognostic factors in chronic lymphocytic leukemia\u2014what do we need to know? Nat Rev Clin Oncol 8:38\u201347","journal-title":"Nat Rev Clin Oncol"},{"key":"1883_CR4","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/092986710790712165","volume":"17","author":"N Capitani","year":"2010","unstructured":"Capitani N, Baldari CT (2010) The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia. Curr Med Chem 17:801\u2013811","journal-title":"Curr Med Chem"},{"key":"1883_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(95)90410-7","volume":"80","author":"S Takayama","year":"1995","unstructured":"Takayama S, Sato T, Krajewski S et al (1995) Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279\u2013284","journal-title":"Cell"},{"key":"1883_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(02)00456-1","volume":"188","author":"H Doong","year":"2002","unstructured":"Doong H, Vrailas A, Kohn EC (2002) What\u2019s in the 'BAG'?\u2014a functional domain analysis of the BAG-family proteins. Cancer Lett 188:25\u201332","journal-title":"Cancer Lett"},{"key":"1883_CR7","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1038\/ncb1001-e237","volume":"3","author":"S Takayama","year":"2001","unstructured":"Takayama S, Reed JC (2001) Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 3:E237\u2013E241","journal-title":"Nat Cell Biol"},{"key":"1883_CR8","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.yexcr.2006.05.023","volume":"312","author":"JN Kassis","year":"2006","unstructured":"Kassis JN, Guancial EA, Doong H, Virador V, Kohn EC (2006) CAIR-1\/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res 312:2962\u20132971","journal-title":"Exp Cell Res"},{"key":"1883_CR9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1074\/jbc.274.2.781","volume":"274","author":"S Takayama","year":"1999","unstructured":"Takayama S, Xie Z, Reed JC (1999) An evolutionarily conserved family of Hsp70\/Hsc70 molecular chaperone regulators. J Biol Chem 274:781\u2013786","journal-title":"J Biol Chem"},{"key":"1883_CR10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.leu.2403219","volume":"18","author":"P Bonelli","year":"2004","unstructured":"Bonelli P, Petrella A, Rosati A et al (2004) BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18:358\u2013360","journal-title":"Leukemia"},{"key":"1883_CR11","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jc.2006-1712","volume":"92","author":"G Chiappetta","year":"2007","unstructured":"Chiappetta G, Ammirante M, Basile A et al (2007) The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 92:1159\u20131163","journal-title":"J Clin Endocrinol Metab"},{"key":"1883_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(01)02728-4","volume":"503","author":"Q Liao","year":"2001","unstructured":"Liao Q, Ozawa F, Friess H et al (2001) The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett 503:151\u2013157","journal-title":"FEBS Lett"},{"key":"1883_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13277-010-0055-3","volume":"31","author":"S Staibano","year":"2010","unstructured":"Staibano S, Mascolo M, Di Benedetto M et al (2010) BAG3 protein delocalisation in prostate carcinoma. Tumour Biol 31:461\u2013469","journal-title":"Tumour Biol"},{"key":"1883_CR14","doi-asserted-by":"crossref","first-page":"10252","DOI":"10.1158\/0008-5472.CAN-07-0618","volume":"67","author":"M Iwasaki","year":"2007","unstructured":"Iwasaki M, Homma S, Hishiya A et al (2007) BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res 67:10252\u201310259","journal-title":"Cancer Res"},{"key":"1883_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.canlet.2011.01.019","volume":"303","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Iwasaki M, Sugio A et al (2011) BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett 303:65\u201371","journal-title":"Cancer Lett"},{"key":"1883_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.cdd.4401167","volume":"10","author":"MF Romano","year":"2003","unstructured":"Romano MF, Festa M, Pagliuca G et al (2003) BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 10:383\u2013385","journal-title":"Cell Death Differ"},{"key":"1883_CR17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4161\/cbt.2.5.524","volume":"2","author":"MF Romano","year":"2003","unstructured":"Romano MF, Festa M, Petrella A et al (2003) BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2:508\u2013510","journal-title":"Cancer Biol Ther"},{"key":"1883_CR18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.febslet.2008.12.032","volume":"583","author":"P Liu","year":"2009","unstructured":"Liu P, Xu B, Li J, Lu H (2009) BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis. FEBS Lett 583:401\u2013406","journal-title":"FEBS Lett"},{"key":"1883_CR19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2007.11.001","volume":"365","author":"HQ Wang","year":"2008","unstructured":"Wang HQ, Liu HM, Zhang HY, Guan Y, Du ZX (2008) Transcriptional upregulation of BAG3 upon proteasome inhibition. Biochem Biophys Res Commun 365:381\u2013385","journal-title":"Biochem Biophys Res Commun"},{"key":"1883_CR20","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.leukres.2008.01.016","volume":"32","author":"BC Valdez","year":"2008","unstructured":"Valdez BC, Murray D, Ramdas L et al (2008) Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk Res 32:1684\u20131697","journal-title":"Leuk Res"},{"key":"1883_CR21","first-page":"838","volume":"18","author":"HY Chen","year":"2010","unstructured":"Chen HY, Liu P, Sun M et al (2010) Bag3 gene expression in chronic lymphocytic leukemia and its association with patients\u2019 prognosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18:838\u2013842","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"1883_CR22","first-page":"257","volume":"27","author":"H Zhu","year":"2012","unstructured":"Zhu H, Liu P, Li J (2012) BAG3: a new therapeutic target of human cancers? Histol Histopathol 27:257\u2013261","journal-title":"Histol Histopathol"},{"key":"1883_CR23","doi-asserted-by":"crossref","unstructured":"Anonymous (2004) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique 15:124\u2013129","DOI":"10.3917\/jib.151.0124"},{"key":"1883_CR24","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D et al (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446\u20135456","journal-title":"Blood"},{"key":"1883_CR25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/1042819021000006547","volume":"43","author":"MJ Keating","year":"2002","unstructured":"Keating MJ, O\u2019Brien S, Kontoyiannis D et al (2002) Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia. Leuk Lymphoma 43:1755\u20131762","journal-title":"Leuk Lymphoma"},{"key":"1883_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.leukres.2007.10.009","volume":"32","author":"W Xu","year":"2008","unstructured":"Xu W, Li JY, Wu YJ et al (2008) Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia. Leuk Res 32:1071\u20131077","journal-title":"Leuk Res"},{"key":"1883_CR27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00277-010-1125-8","volume":"90","author":"HJ Dong","year":"2011","unstructured":"Dong HJ, Zhou LT, Zhu DX et al (2011) The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13). Ann Hematol 90:709\u2013717","journal-title":"Ann Hematol"},{"key":"1883_CR28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.leukres.2010.03.011","volume":"34","author":"AG Buggins","year":"2010","unstructured":"Buggins AG, Pepper CJ (2010) The role of Bcl-2 family proteins in chronic lymphocytic leukaemia. Leuk Res 34:837\u2013842","journal-title":"Leuk Res"},{"key":"1883_CR29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/emm.2005.76","volume":"37","author":"YJ Seo","year":"2005","unstructured":"Seo YJ, Jeon MH, Lee JH et al (2005) Bis induces growth inhibition and differentiation of HL-60 cells via up-regulation of p27. Exp Mol Med 37:624\u2013630","journal-title":"Exp Mol Med"},{"key":"1883_CR30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2009.23","volume":"23","author":"A Rosati","year":"2009","unstructured":"Rosati A, Di Salle E, Luberto L et al (2009) Identification of a Btk-BAG3 complex induced by oxidative stress. Leukemia 23:823\u2013824","journal-title":"Leukemia"},{"key":"1883_CR31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2010.68","volume":"24","author":"E Cesaro","year":"2010","unstructured":"Cesaro E, Montano G, Rosati A et al (2010) WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia 24:1204\u20131206","journal-title":"Leukemia"},{"key":"1883_CR32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","volume":"100","author":"A Krober","year":"2002","unstructured":"Krober A, Seiler T, Benner A et al (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100:1410\u20131416","journal-title":"Blood"},{"key":"1883_CR33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","volume":"115","author":"DF Jelinek","year":"2001","unstructured":"Jelinek DF, Tschumper RC, Geyer SM et al (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 115:854\u2013861","journal-title":"Br J Haematol"},{"key":"1883_CR34","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1080\/10428190600947727","volume":"47","author":"A Hayat","year":"2006","unstructured":"Hayat A, O\u2019Brien D, O\u2019Rourke P et al (2006) CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leuk Lymphoma 47:2371\u20132379","journal-title":"Leuk Lymphoma"},{"key":"1883_CR35","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","volume":"194","author":"A Rosenwald","year":"2001","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639\u20131647","journal-title":"J Exp Med"},{"key":"1883_CR36","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS et al (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944\u20134951","journal-title":"Blood"},{"key":"1883_CR37","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","volume":"85","author":"H Dohner","year":"1995","unstructured":"Dohner H, Fischer K, Bentz M et al (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580\u20131589","journal-title":"Blood"},{"key":"1883_CR38","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2001-11-0066","volume":"100","author":"K Lin","year":"2002","unstructured":"Lin K, Sherrington PD, Dennis M et al (2002) Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 100:1404\u20131409","journal-title":"Blood"},{"key":"1883_CR39","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1038\/sj.onc.1203043","volume":"18","author":"JH Lee","year":"1999","unstructured":"Lee JH, Takahashi T, Yasuhara N et al (1999) Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18:6183\u20136190","journal-title":"Oncogene"},{"key":"1883_CR40","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1074\/jbc.M808656200","volume":"284","author":"AT Jacobs","year":"2009","unstructured":"Jacobs AT, Marnett LJ (2009) HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 284:9176\u20139183","journal-title":"J Biol Chem"},{"key":"1883_CR41","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1073\/pnas.0907696107","volume":"107","author":"M Ammirante","year":"2010","unstructured":"Ammirante M, Rosati A, Arra C et al (2010) IKK\u03b3 protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA 107:7497\u20137502","journal-title":"Proc Natl Acad Sci USA"},{"key":"1883_CR42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.bbrc.2008.02.112","volume":"369","author":"ZX Du","year":"2008","unstructured":"Du ZX, Meng X, Zhang HY, Guan Y, Wang HQ (2008) Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun 369:894\u2013898","journal-title":"Biochem Biophys Res Commun"},{"key":"1883_CR43","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/j.1476-5381.2009.00455.x","volume":"158","author":"HQ Wang","year":"2009","unstructured":"Wang HQ, Liu BQ, Gao YY et al (2009) Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol 158:1405\u20131412","journal-title":"Br J Pharmacol"},{"key":"1883_CR44","doi-asserted-by":"crossref","first-page":"e26097","DOI":"10.1371\/journal.pone.0026097","volume":"6","author":"S Aveic","year":"2011","unstructured":"Aveic S, Pigazzi M, Basso G (2011) BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia. PLoS One 6:e26097","journal-title":"PLoS One"},{"key":"1883_CR45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbrc.2010.08.092","volume":"400","author":"M Iwasaki","year":"2010","unstructured":"Iwasaki M, Tanaka R, Hishiya A et al (2010) BAG3 directly associates with guanine nucleotide exchange factor of Rap1, PDZGEF2, and regulates cell adhesion. Biochem Biophys Res Commun 400:413\u2013418","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1883-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1883-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1883-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T13:59:47Z","timestamp":1596376787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1883-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,25]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1883-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,25]]}}}